Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132880) titled 'Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features' on Sept. 19.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Zhongshan People's Hospital
Condition:
Nasopharyngeal carcinoma
Intervention:
Gold Standard:Histopathological examination of nasopharyngeal biopsy specimens.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: Target condition:100;Difficult condition:397
Countries of Recruitment:
China
To know more, visit https:...